Amanta Healthcare Ltd Quarterly Results: Standalone & Consolidated Reports

Quarterly Results

Results Snapshot

YoYQoQ

Figures in Cr

Standalone Quarterly Results

Mar'26

Dec'25

Sep'25

Jun'25

Mar'25

Dec'24

Sep'24

Quarterly Analysis Highlights - QoQ

Net Sales

QoQ Growth in quarter ended Mar 2026 is 3.36% vs 5.08% in Dec 2025

Standalone Net Profit

QoQ Growth in quarter ended Mar 2026 is 19.44% vs 282.64% in Dec 2025

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Mar 2026 is -2.67% vs 4.85% in Dec 2025

Interest

QoQ Growth in quarter ended Mar 2026 is -16.01% vs -1.75% in Dec 2025

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Mar 2026 has fallen from Dec 2025

Compare Quarterly Results Of Amanta Healthcar With

Select Peers

Figures in Cr

Standalone Quarterly Results

Change(INR)

Change(%)

Net Sales

76.99

63.38

13.61

21.47%

Other Operating Income

0.00

Total Operating income

76.99

63.38

13.61

21.47%

Raw Material Cost

25.13

33.02

-7.89

-23.89%

Purchase of Finished goods

3.55

0.00

3.55

(Increase) / Decrease In Stocks

0.19

-7.34

7.53

102.59%

Employee Cost

11.09

12.06

-0.97

-8.04%

Power Cost

0.00

Manufacturing Expenses

0.00

12.15

-12.15

-100.00%

Selling and Distribution Expenses

0.00

Other Expenses

22.08

7.29

14.79

202.88%

Total Expenditure (Excl Depreciation)

62.04

57.18

4.86

8.50%

Operating Profit (PBDIT) excl Other Income

14.95

6.20

8.75

141.13%

Other Income

1.66

0.97

0.69

71.13%

Operating Profit (PBDIT)

16.61

7.17

9.44

131.66%

Interest

4.25

1.34

2.91

217.16%

Exceptional Items

0.00

Gross Profit (PBDT)

12.36

5.83

6.53

112.01%

Depreciation

4.75

2.66

2.09

78.57%

Profit Before Tax

7.62

3.18

4.44

139.62%

Tax

2.09

0.94

1.15

122.34%

Provisions and contingencies

0.00

Profit After Tax

5.53

2.23

3.30

147.98%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

5.53

2.23

3.30

147.98%

Equity Capital

38.83

3.02

35.81

1,185.76%

Face Value

10.00

0.00

Reserves

0.00

Earnings per share (EPS)

1.42

7.38

-5.96

-80.76%

Diluted Earnings per share

1.61

7.39

-5.78

-78.21%

Operating Profit Margin (Excl OI)

19.42%

9.78%

0.00

9.64%

Gross Profit Margin

16.05%

9.20%

0.00

6.85%

PAT Margin

7.18%

3.52%

0.00

3.66%

Public Share Holdings (%)

0.00%

0.00

0.00%

Pledged Promotor Holding (%)

0.00%

0.00

0.00%

Quarterly - Net Sales

Net Sales 76.99 Cr

in Mar 2026

Figures in Cr

QoQ Growth in quarter ended Mar 2026 is 3.36% vs 5.08% in Dec 2025

YoY Growth in quarter ended Mar 2026 is 6.84%

Quarterly - Standalone Net Profit

Standalone Net Profit 5.53 Cr

in Mar 2026

Figures in Cr

QoQ Growth in quarter ended Mar 2026 is 19.44% vs 282.64% in Dec 2025

YoY Growth in quarter ended Mar 2026 is -7.21%

Quarterly - Operating Profit (PBDIT)

Operating Profit (PBDIT) 14.95 Cr

in Mar 2026

Figures in Cr

QoQ Growth in quarter ended Mar 2026 is -2.67% vs 4.85% in Dec 2025

YoY Growth in quarter ended Mar 2026 is -21.15%

Quarterly - Interest

Interest 4.25 Cr

in Mar 2026

Figures in Cr

QoQ Growth in quarter ended Mar 2026 is -16.01% vs -1.75% in Dec 2025

YoY Growth in quarter ended Mar 2026 is -32.32%

Quarterly - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 19.42%

in Mar 2026

Figures in %

QoQ Growth in quarter ended Mar 2026 has fallen from Dec 2025

YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025